TRT and LUTS. Mick Jagger, 70 years. PRISM IV Sept 2014

Similar documents
Natural Hair Transplant Medical Center, Inc Dove Street, Suite #250, Newport Beach, CA Phone

Clinical impact of type I and type II 5 alpha-reductase inhibition in prostatic disease: review and update 아주대학교김선일

PACKAGE LEAFLET: INFORMATION FOR THE USER. FINASTERIDE 1 MG FILM-COATED TABLETS (finasteride)

FINASTERIDE (PROPECIA, PROSCAR) SIDE EFFECT & CONSENT FORM

Elements for a public summary

Male pattern baldness is the most common type of balding among males. It affects roughly, 50% of men by the age of 50,

FINCAR Tablets (Finasteride)

Reproductive DHT Analyte Information

1001 West Broadway, Vancouver, BC V6H 4B1. Topical Finasteride

Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor

Elements for a Public Summary. Overview of disease epidemiology

Issues. What is a low testosterone? Who needs testosterone therapy? Benefits/adverse effects of testosterone replacement Treatment options

Secrets of Abang Sado : Effects of testosterone therapy. Azraai Nasruddin

Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH

Androgenes and Antiandrogenes

PHYSICIANS CIRCULAR FINASTERIDE PROSCAR. Tablet 5-Alpha Reductase Inhibitor

This is an English translation of the original Chinese instruction leaflet generated by Google Translate. No amendments were made.

M0BCore Safety Profile. Pharmaceutical form(s)/strength: 5 mg SE/H/PSUR/0002/006 Date of FAR:

The Science of. NUTRICULA Longevity Journal

Skin metabolism of steroid hormones as endogenous compounds?

Prostate enlargement, also known as benign prostatic hyperplasia

Update on the use of dutasteride in the management of benign prostatic hypertrophy

Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

DUPROST Capsules (Dutasteride)

EUROPEAN UROLOGY 57 (2010)

MALE PATTERN BALDNESS

Clinical Significance of 5 -Reductase Activity

Sue Marty, Ph.D., D.A.B.T. The Dow Chemical Company TERA Endocrine Workshop April 23, 2013

Maximum Hair Minimum Loss

Safety and Tolerability of the Dual 5a-Reductase Inhibitor Dutasteride in thetreatment of Benign Prostatic Hyperplasia

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

EFFECTS OF REVIVOGEN SCALP THERAPY ON TESTOSTERONE METABOLISM IN RECONSTRUCTED HUMAN EPIDERMIS

Oncologia Molecular, Porto, Portugal; 3 WSS im. L. Rydygiera, Krakow, Poland;

SUMMARY OF PRODUCT CHARACTERISTICS

Efficacy and Safety of Long-TermTreatment with the Dual 5a-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic Hyperplasia

TESTOFEN. Anabolic & Androgenic Activity GENCOR PACIFIC, INC. Fenugreek Extract standardized for FENUSIDE TM. Copyright 2005 by Gencor Pacific, Inc.

Natural estrogens estradiol estrone estriol

Summary. Introduction. Dow Stough, MD

The ICL Insider. Lab Testing: Testosterone. In This Issue. The Debate

NEW ZEALAND DATA SHEET. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film coated tablet contains 1 mg of finasteride.

PROPECIA finasteride 1 mg tablet

DOSAGE FORMS AND STRENGTHS

FULL PRESCRIBING INFORMATION

PROPECIA Tablets Merck Sharp & Dhome

Insight into male menopause'

Buy The Complete Version of This Book at Booklocker.com:

SUMMARY OF PRODUCT CHARACTERISTICS

It is estimated that 24% to 90% of US men older than the age of

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Associate Professor Geoff Braatvedt

PRODUCT INFORMATION. PROPECIA (finasteride) Tablets NAME OF THE MEDICINE

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

SUMMARY OF PRODUCT CHARACTERISTICS

AUSTRALIAN PRODUCT INFORMATION PROPECIA (finasteride) Tablets QUALITATIVE AND QUANTITATIVE COMPOSITION

Finasteride 1mg film-coated tablets (Pharmacare )

Product Monograph. Sandoz Dutasteride

Jeremiah Murphy, MD Mercy Urology Clinic. October 21, 2017

Donald W. Morrish, MD, PhD, FRCPC Presented at Mountain Man: Men's Health Conference, May Terry s Testosterone

DUTASTERIDE capsules, for oral use Initial U.S. Approval: 2001

New Zealand Data Sheet

PROPECIA (Finasteride) Tablets, 1 mg

Testosterone Use and Effects

SUMMARY OF PRODUCT CHARACTERISTICS

PRODUCT INFORMATION. PROPECIA (finasteride) Tablets NAME OF THE MEDICINE

Dutasteride Avodart Softgel Capsule

The capsules are opaque, yellow, oblong soft gelatin capsules filled with an oily and yellowish liquid, without printing.

The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia

PRODUCT INFORMATION TESTOVIRON DEPOT. (testosterone enanthate)

Benign prostatic hyperplasia (BPH), which leads to an

TESTOFEN HUMAN CLINICAL TRIAL GENCOR PACIFIC, INC. Copyright 2006 by Gencor Pacific, Inc.

SILOFAST D Capsules (Silodosin + Dutasteride)

CONFÉRENCE À SUCCÈS EN SCIENCES DE LA VIE : ENDOCEUTICS

ANNEX 3 TO THE DRAFT REPORT OF THE OECD VALIDATION OF THE RAT HERSHBERGER BIOASSAY: PHASE 2

BEST FINASTERIDE IN INDIA

Package leaflet: Information for the user Finasteride 5 mg Film-coated Tablets Finasteride

Dr Tarza Jamal Pharmacology Lecture 2

STUDY OF THE EFFECT OF AN EXTRACT OF Serenoa repens on the production of the 5-α reductasa enzyme

PROPECIA (finasteride) Tablets, 1 mg

PRODUCT INFORMATION CF 3

HIGHLIGHTS OF PRESCRIBING INFORMATION

european urology 55 (2009)

Package Leaflet: Information for the patient. Sustanon 250, 250 mg/ml, solution for injection (testosterone esters)

ARE FINASTERIDE SIDE EFFECTS PERMANENT

PRODUCT INFORMATION. Apo-Finasteride 1 (Finasteride Film-coated Tablets 1 mg)

Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients

Adverse effects of anabolic androgenic steroids abuse on gonadal function, glucose homeostasis and cardiovascular function

URIMAX D Tablets (Tamsulosin hydrochloride + Dutasteride)

Efficacy and tolerability of the dual 5a-reductase inhibitor, dutasteride, in the treatment of benign prostatic hyperplasia in African-American men

AVODART (dutasteride) Soft Gelatin Capsules

Priyam Bhaskar Rai, Pragya Khushwaha*, Nitish Jain, Swati Gupta

PRODUCT INFORMATION CF 3

Proviron. Proviron Functions & Traits: (Mesterolone)

population Completed double-blind 458 (67.7) 445 (65.0) study n (%)

Female testosterone level chart

MI Androgen Deficiency Hypogonadism

Formally known as anabolic steroids or anabolic-androgenic steroids, but they are sometimes called 'roids', 'gear' or 'juice'.

HGH for Sale Natural Anti-Aging Human Growth Hormone

Gynaecomastia. Benign breast conditions information provided by Breast Cancer Care

PRODUCT INFORMATION PROVIRON

Transcription:

TRT and LUTS Mick Jagger, 70 years PRISM IV Sept 2014

Combination of LUTS and LOH In ageing male : -LUTS increases -LOH increases So: the combination is a common clinical scenario

TRT and LUTS Startingpoint / first thought: Treatment of LUTS prevails treatment of LOH

TRT and LUTS Guidelines: TRT relative contra-indicated if IPSS 21 points (no data!) - Wang, ISA, ISSAM, ASA etc, 2012 - Buvat, 2010 - Dohle, EAU, 2012

TRT and LUTS; what do we know? Gradual increase of prostate volume, concomitant with progressive decline of T Hypogonadism affects 20% of elderly men with LUTS In men with Metabolic Syndrome : LUTS earlier in life Although there is no consistent relationship between TT and ft and LUTS/BPH: in eugonadal middle-aged men(lee, 2014) May be : T is the common link between : Advancing age LUTS MetS Francomano, Urology 83 (1), 2014 Rohrmann, Urology 69, 2007 Litman,BJU Int. 100,2007

TRT and LUTS; what is in the literature? Mild LUTS improve with TRT, Yassin, World J Urol, 2013. Mild LUTS was stable after 5y of TRT, Francomano, Urology, 2014, 83,1 -signifant lower incidence of prostatitis: T prevents prostatitis? Severe LUTS and TRT: no data!

TRT and LUTS Hypothesis: - Testosteron may act on the structures of the lower urinary tract: Some prove: Androgenreceptors on urethra and bladder epithelial cells are detected T maintains reflex activity of the pelvic autonomic nervous system Chavalmane, J Sex Med 8 2010,

TRT and LUTS Two Questions: -Is TRT bad for LUTS? -Is LUTS-therapy bad for LOH?

TRT and LUTS Is TRT bad for LUTS? - is TRT bad for bladder as the cause of LUTS? Probably not! - is TRT bad for BPH as the cause of LUTS? We don t know! no data

TRT and LUTS First recommendation: -No TRT in severe LUTS, but no data available -Just treat severe LUTS first

TRT and LUTS Two Questions: -Is TRT bad for LUTS? -Is LUTS-therapy bad for LOH?

TRT and LUTS Is LUTS-therapy bad for LOH: bad for sexual functions, bad for TRT? LUTS-Treatments: -alfa-blockers -5alfa-reductase-inhibitors -anti-cholinergic drugs in urge-patients -TURP and other operations

TRT and LUTS BPH-treatments: -alfablockers: alfuzosine dry orgasm; ED tamsulosine dry orgasm; ED silodine dry orgasm; ED -PDE-5-I tadalafil improves erections and LUTS/BPH!! -PDE-5-I plus alfablockers improves LUTS and ED -5ARI s: finasteride dutasteride -TURP: 10% improvement / 10% worsening of ED Leliefeld, BJU Int 2002, 89, 208-13 Gacci, Eur Urol 2011;60:809-25 Huilei Yan, J Sex Med 2014;11:1539-45

CanTRT-patients with LUTS benefit from Dutasteride? Could be conflicting because: Effects of Dutasteride : Effects of TRT: -90% decrease of DHT in serum and prostate -prostate volume decreases ± 30 % -PSA decreases ±50 % after 3-6 months -Sexual side effects : ± 30 % -Testosterone increases -DHT increases Rittmaster, 2008, Roehrborn, 2011 Andriole, 2004 Toren, 2013

Question: Is Dutasteride therapy still effective in TRT-patiënts with LUTS? or: What is the influence of Dutasteride on : -PSA -prostate volume -sexual symptoms in patients that are on stable TRT

Randomised placebo-controlled study in patients stable on TRT TRT + dutasteride (n=11) TRT plus placebo(n=11) PSA change: 23,2% decrease no change Prostate volume: 6,65% decrease no change Sexual side effects: a trend (MSHQ) no change Kacker, R et al, Andrologia 2014; 20, 1-5

CanTRT-patients with LUTS benefit from Dutasteride? Possible Conclusions with caution : -PSA decreases less: 23,2%% versus 50% -Prostate volume decreases less: 6,65% versus 30% -Sexual side effects: a trend to still appear despite TRT DHT important for sexual function Kacker R, et al, Andrologia, 2014; 20, 1-5

CanTRT-patients with LUTS benefit from Dutasteride? In simple language might be stated: Dutasteride in TRT-patients brings : -less decrease of PSA More large volume studies are necessary -less prostate volume reduction -still sexual side effects - LUTS not examined: no data

J Sex Med 2012;9:2927-32 Sex Med Rev 2014;2: 24-35

Time to learn more about Finasteride and Dutasteride

Finasteride : 5 alfa reductase-2-inhibitor : reduces DHT -Male pattern hair loss: 1977 1mg -a sign of virility, due to high T/DHT -high DHT means baldness -high 5α-reductase-2-activity in skin of head -BPH: 1992 5 mg

Baldness: sign of virility

Persistent sexual side effects of 1mg in Propecia In 2008: Swedish Medical Products Agency: persistent ED after discontinuation In 2009: Agency in UK : difficulty having erection after discontinuation In 2011: Traisch JSM 8:872-84: Persistent ED, low libido and depression:1 case In 2011: Irwig, JSM 8:1747-53: Persistent sexual side effects: series of 71 men In 2012: Irwig, JSM 9:2927-32: Persistent sexual side effects: Permanent? - Inclusion: men with SD for 3 months despite cessation of finasteride 89 % still had sexual disfunction at mean FU of 14 months (n=54)

Rates of withdrawal because of sexual side effects of 5 mg in BPH Lowe,McConnel, Urology, 2003;61:791-6 1,3% Prospectstudy, CMAJ, 1996,155:1251-9 long duration PlessStudy, Urology, 2003:61:579-84 4% Whether the sexual side effects ever resolved, has not been published!!

Finasteride : background Three isoforms of 5α-reductase: -Type I: in brain, liver, muscle, skin and little in the prostate -Type II: in epididymis, hair follicles, liver, prostate and seminal vesicles -Type III: in brain, heart, lung, pancreas, colon, stomach, liver, muscle, prostate and testicles Attention: Type III at higher levels than I and II ; potent inhibition by Finasteride and Dutasteride! Yamana, Horm.Mol Biol Clin Invest 2010;2:293-9

Finasteride : background Is a synthetic steroid that acts as an alternative substrate for the 5α-reductase enzymes Is lipophilic: can cross the blood-brain barrier Inhibition of formation of not only DHT but also of: -allopregnanolone (ALLO), a progesterone metabolite -androsterone -epiandrosterone -THDOC -and many other steroids Duskova, Prague Med Rep 2009; 110:222-30

Finasteride and Neurosteroids Neurosteroids: - steroids that are synthesized in the brain - or metabolized in the brain from steroids from gonads or adrenal glands - play a role in neurogenesis, neuroprotection, synaptic formation, plasticity of the brain and myelination Finasteride: - can alter the concentrations of neurosteroids like ALLO and THDOC - decreases neurogenesis and proliferation of neural precursor cells in mice Römer Pharmacopsychiatry 2010;43:174-8 Irwig Sex Med Rev 2014; 2: 24-35

Finasteride : background The 5α-reductase Type 2 that binds to finasteride have significant genetic variation with probably different affinities for finasteride In other words: finasteride can act different in different individuals Andersson, Proc Natl Acad Sci USA 1990;87:3640-4

Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5 Alpha Reductase Inhibitor Therapy In vivo erectile response in rats after pelvic nerve stimulation Controls 8 weeks dutasteride 6 weeks dutasteride and 2 weeks wash out The Journal of Sexual Medicine, CV Öztekin.e.a. Volume 9, Issue 7, pages 1773-1781, 8 MAY 2012 DOI: 10.1111/j.1743-6109.2012.02759.x http://onlinelibrary.wiley.com/doi/10.1111/j.1743-6109.2012.02759.x/full#f1

Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5 Alpha Reductase Inhibitor Therapy In vitro bath responses of CC smooth muscle Controls 8 weeks dutasteride 6 weeks dutasteride and 2 weeks wash out The Journal of Sexual Medicine, CV Öztekin e.a. Volume 9, Issue 7, pages 1773-1781, 8 MAY 2012 DOI: 10.1111/j.1743-6109.2012.02759.x http://onlinelibrary.wiley.com/doi/10.1111/j.1743-6109.2012.02759.x/full#f4

Finasteride and erectile disfunction Already in 1981 shown to be harmful for erections in male rats DHT in castrated rats improves erections So: Dutasteride has detrimental effects on EF in rats, proven by: -decreased erectile response with cavernosal stimulation -strips of smooth muscle :contraction and stimulation -increased collagen deposition in cavernous tissue -26% lower weight of corpora cavernosa than in controls Lit: Irwig 2014 Sex Med Rev 2:24-35

Finasteride and the persistent side effects Erectiele disfunction Low libido and decreased orgasm Depression Decrease in Alcohol consumption in young men and animal models Irwig, MS Sex Med Rev 2014; 2: 24-35 Overview of the literature

Finasteride and depression in former users Depressive symptoms in finasteride group : 75% in control group : 10% Suicidal thoughts in finasteride group : 44% in control group : 3% Irwig J Clin Psychiatry 2012;73:1220-3

Finasteride and decrease in alcohol consumption Decrease of alcoholconsumption in 65% (41 of 63 subjects) Quitting drinking entirely: 18 of 63 subjects because of effects of alcohol on mental function: decreased euphoria Mechanism: modulation by ALLO in male mice and rats Janak 1998, Alcohol Clin Exp Res 22:1106-12

Finasteride and side effects Why so late reported in the literature? -Incidence of persistent side effects is less than 1% -general underreporting of adverse effects of medications -no validated instrument used in RCT of 5α-reductase inhibitors FDA in 2012: persistent sexual side effects on the label of finasteride FDA in 2010: depression on the label of Propecia

Finasteride and side effects Finasteride alters the levels of multiple hormones and neurosteroids Studying the brain of living humans will be difficult Persistent effects : intriguing and bothersome for men who suffer - 89% still sexual disfunction 14 months after stopping Genetics presumably determine the individual s risk for a side effect At now: no test available to predict if the patient will be unlucky!! At now: no pharmacological therapy available other than PDE-5-I TRT did not help Irwig 2012 J Sex Med 9:2927-32

Finasteride and side effects Messages / Summing up: - Literature on long term side effects comes mainly from 1mg finasteride - Literature on long term sexual side effects of finasteride /dutasteride in BPH is lacking - Literature on sexual side effects concerns mainly experiments in rats and mice - FDA warns for persistent sexual side effects and depression since 2010/2012 - It is not possible to estimate the risk of persistent (sexual) side effects anno 2014 - Finasteride can lower many neurosteroids and not only DHT

Finasteride and side effects Prescribers and users should be aware of the potential serious persistent risks of finasteride and dutasteride

Take home messages No TRT in severe LUTS-patients; but no data Treat severe LUTS before starting TRT Many LUTS-treatments can be : bad for LOH-patients Finasteride / Dutasteride can give sexual disfunctions/depressions Finasteride / Dutasteride can give persistent sexual disfunctions! Finasteride / Dutasteride only in patients with prostate volume 40 gram Discuss side effects with your patients

The End

Finasteride and Neurosteroids In the brain: -G-aminobutyric acid (GABA) : major inhibitory neurotransmitter - 2 important neurotransmitters are modulators of the GABA receptor: -ALLO and THDOC -The sensitivity of the GABA receptor can be altered by: -ALLO -chronic steroid administration -age, stress and social isolation Majewska, Science1986,;232:1004-7

Finasteride and Low libido and Decreased Orgasm Difficult to study ; mechanisms less clear; indirect evidence Sexual excitation : neurotransmitter: norepinepfrine and dopamine Inhibition of sexual arousal : serotonine and opioids -5α reductase is present in many of the brain regions linked to sexual desire -reduction of neurosteroids leads to loss of neuroprotection: sexual desire Römer Pharmacopsychiatry 2010; 43 :174-8